Back to INBX
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC → INBX
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC INBX Position History
Inhibrx Biosciences, Inc. • Healthcare
Quarters held
6
Latest value
$1.8M
Q3 2026
Peak value
$1.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $790 |
| Q1 2026 | $5K |
| Q2 2026 | $6K |
| Q2 2026 | $1.9M |
| Q3 2026 | $60K |
| Q3 2026 | $1.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.8M | 18.3K | — | — |
| Q3 2026 | $60K | 599 | — | — |
| Q2 2026 | $1.9M | 20.0K | — | — |
| Q2 2026 | $6K | 67 | — | — |
| Q1 2026 | $5K | 67 | — | — |
| Q4 2025 | $790 | 10 | — | — |
Other funds holding INBX
$271.7M
$172.4M
$131.2M
$129.3M
$126.4M
$125.3M